Our Recommendations
- Best Practice Portal (2022)
- Предложение для всех, кто хочет помочь близким людям. Алкоголь, медикаменты, никотин, наркотики, зависимое поведение (2014)
- Best practice portal: standards and guidelines (2019)
- Module: Disorders due to substance abuse mhGAP (2019)
- European Drug Prevention Quality Standards (2019)
New Publications
- Часто задаваемые вопросы на тему «Зависимость» (2018)
- Integrated operational framework for mental health, brain health and substance use (2024)
- The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016 (2018)
- The Global Drug Policy Index 2021 (2021)
- EU Drug Strategy (2022)
Filter
98
Featured
Recommendations
8
New Publications
7
Language
Document type
No document type
73
Studies & Reports
8
Guidelines
5
Fact sheets
4
Resource Platforms
3
Manuals
2
Strategic & Response Plan
2
Brochures
1
Countries / Regions
Western and Central Europe
7
Global
4
North Macedonia
2
Eastern Europe
2
Russia
2
India
2
Tajikistan
1
Nepal
1
Colombia
1
Thailand
1
Kenya
1
Mexico
1
Serbia
1
Ghana
1
Albania
1
Senegal
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Morocco
1
Mozambique
1
Africa
1
Latin America and the Carribbean
1
Hungary
1
West and Central Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Jamaica
1
Norway
1
Portugal
1
Argentina
1
Lebanon
1
South Africa
1
Uganda
1
Brazil
1
Georgia
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
4
Key Resources
1
ERRATA
2214-9996/a 2014 Icahn School of Medicine at Mount Sinai
Department of Medical Education Icahn School of Medicine at Mount Sinai, New York
http://dx.doi.org/10.1016/j.aogh.2014.10.003
Как близкий человека, страдающего наркоманией или находящегося под угрозой, вы находитесь в тяжёлом положении. Вы хотите понять его и помочь жить нормальной семей...
Proporciona herramientas para ayudar a organizar un día para el diálogo comunitario acerca de la salud mental. Habla sobre la logística de encontrar un lugar, formar una red de socios; reclutar participantes y facilitadores, organizar la reunión e identificar las medidas de seguimiento. Nota: Ha...
A summary of the national drug situation
The WHO Global Burden of Disease (GBD) study measures the burden of
disease using the disability-adjusted life year metric (DALY). The DALY metric
was developed to assess the burden of disease consistently across diseases,
risk factors and regions. A consistent and comparative description of the ...
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
A summary of the national drug situation
El presente manual trata de proporcionar información sencilla, adecuada y basada en datos
científicos a los prestadores de servicios de salud, especialmente en los países de ingresos bajos y medios, para que puedan administrar tratamientos farmacológicos a las personas con trastornos mentales. ...
Manual for use in primary care
Harm reduction: evidence, impacts and challenges
-10-
The ASSIST package is developed to help the primary health professionals to detect and manage substance use and related problems in primary and general medical care settings.
Download the ASSIST screening test version 3.0 and feedback card
The ASSIST screening test version 3.0 is availa...
Manual para uso en la atención primaria
The present booklet is about gender-responsive substance abuse treatment services for women. It is part of the United Nations Office on Drugs and Crime (UNODC) project to develop tools to support the development and improvement of substance abuse treatment services, based on evidence from the litera...
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (which may or may not have been medically prescribed)
